在胃肠道流体瘤患者的IV型过敏反应后伊马替尼布脱敏-A病例报告
Maud B A van der Kleij1,2, Tristan V M Bruijn3,4, Raween W Kalicharan5
1Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
Cancer reports (Hoboken, N.J.)
|June 11, 2025
概括
伊马替尼布过敏反应可以管理. 无敏化允许在严重的不良事件发生后,重新引入imaatinib,用于胃肠道 stromal瘤 (GIST) 或慢性髓性白血病 (CML) 的患者.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 伊马替尼是慢性髓性白血病 (CML) 和胃肠道 stromal 瘤 (GIST) 的关键疗法.
- 虽然一般耐受良好,但可能会出现过敏反应,需要停止治疗.
- 伊马替尼的临床益处通常需要探索其重新引入的策略.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K